Company / Operating Cash Flow
KYNTRA BIO, INC. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$138.0M
FY2025
5-year range
-$315.0M / $81.6M
FY2021-FY2025
Trend
+56.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow returned to growth in FY2025 after 2 years of decline, reaching -$138M.
Based on SEC 10-K filings.
-$138M in FY2025.
Declined from -$82M to -$138M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 56.2% year-over-year.
- Peak operating cash flow was recorded in FY2022.
- Lowest operating cash flow in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$138.0M | +56.2% |
| FY2024 | -$315.0M | -283.1% |
| FY2023 | -$82.2M | -200.8% |
| FY2022 | $81.6M | +203.7% |
| FY2021 | -$78.7M | -3.4% |
| FY2020 | -$76.1M | -14.5% |
| FY2019 | -$66.5M | -1035.7% |
| FY2018 | $7.1M | +138.3% |
| FY2017 | -$18.6M | -182.9% |
| FY2016 | $22.4M | -13.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026